Glycotope was founded in 2001 in Berlin, and now has locations in Heidelberg and Berlin. The founding members have drawn on their extensive know-how, gained as research group leaders at Berliner Max-Delbrück-Zentrum for molecular medicine, as founders of a medical technology company in the area of Life Sciences and have thus made Glycotope a successful company focusing on the optimization of glycosylation in preparation for immunotherapy. It also includes the development of therapeutic antibodies, which achieve better therapeutic success with an optimized glycosylation pattern because they are more similar to endogenous antibodies than to traditionally produced antibodies. In this area Glycotope can boast numerous renowned customers such as Sanofi Aventis, Novartis or Trigen. The same technologies are used for the development and production of high-quality antibodies.

On antibodies-online you will find more than 40 high-quality primary antibodies from Glycotope. These primary antibodies are monoclonal and generated in mice to ensure optimal selectivity against the searched antigen. Almost all of Glycotype’s primary antibodies available on antibodies-online are acceptable for application in ELISAs. In addition, these diverse primary antibodies can be adopted in applications such as Western blot, immunohistochemistry, immunofluorescence, as well as in thin-layer-chromatographic overlay (TCL Overlay).

Of course you can also find suitable secondary antibodies in the great range of products on antibodies-online. The Glycotope offer is particularly addressed to researchers who work in the areas of extracellular matrix, oncology and immunology, and especially with surface receptors of immune cells and CD antigens. Only on antibodies-online do you have the possibility of comparing products of Glycotope directly with those of our other suppliers to find the tailor-made antibody for your project.